Martin A. Smith - 01 Sep 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Martin A. Smith
Issuer symbol
IDXX
Transactions as of
01 Sep 2025
Net transactions value
-$3,235
Form type
4
Filing time
03 Sep 2025, 17:56:31 UTC
Previous filing
18 Feb 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Martin Alexander Executive Vice President ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Martin A. Smith 03 Sep 2025 0001621358

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +18 +1.3% $0.000000 1,439 01 Sep 2025 Direct F1
transaction IDXX Common Stock Tax liability $3,235 -5 -0.35% $647.09 1,434 01 Sep 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Restricted Stock Unit Options Exercise -18 -100% 0 01 Sep 2025 Common Stock 18 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 28.709 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.
F2 Closing price of Issuer common stock on the Nasdaq Global Select Market on August 29, 2025.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in four annual installments, beginning September 1, 2022.
F4 Not applicable.